Journal of Biological Chemistry · 2004 · 164 citations · 28 references
Life SciencesBiochemistryMolecular BiologyCell SignalingMolecular Cell BiologySignal TransductionCytokine Receptor SignalingPhosphoinositide SignalingProtein Kinase CascadesProtein PhosphorylationAntigen Receptor SignalingIge-mediated Mast Cell ResponsesPhosphatidylinositol 3-Kinase-akt PathwayPhosphatidylinositol 3-Kinase-akt SignalingPhosphoinositide 3-Kinase-akt ActivationProtein Kinase C SignalingStem Cell Factor SignalingStem Cell Growth Factor Signaling
Akt (= protein kinase B), a subfamily of the AGC serine/threonine kinases, plays critical roles in survival, proliferation, glucose metabolism, and other cellular functions. Akt activation requires the recruitment of the enzyme to the plasma membrane by interacting with membrane-bound lipid products of phosphatidylinositol 3-kinase. Membrane-bound Akt is then phosphorylated at two sites for its full activation; Thr-308 in the activation loop of the kinase domain is phosphorylated by 3-phosphoinositide-dependent kinase-1 (PDK1) and Ser-473 in the C-terminal hydrophobic motif by a putative kinase PDK2. The identity of PDK2 has been elusive. Here we present evidence that conventional isoforms of protein kinase C (PKC), particularly PKCβII, can regulate Akt activity by directly phosphorylating Ser-473 in vitro and in IgE/antigen-stimulated mast cells. By contrast, PKCβ is not required for Ser-473 phosphorylation in mast cells stimulated with stem cell factor or interleukin-3, in serum-stimulated fibroblasts, or in antigen receptor-stimulated T or B lymphocytes. Therefore, PKCβII appears to work as a cell type- and stimulus-specific PDK2. Akt (= protein kinase B), a subfamily of the AGC serine/threonine kinases, plays critical roles in survival, proliferation, glucose metabolism, and other cellular functions. Akt activation requires the recruitment of the enzyme to the plasma membrane by interacting with membrane-bound lipid products of phosphatidylinositol 3-kinase. Membrane-bound Akt is then phosphorylated at two sites for its full activation; Thr-308 in the activation loop of the kinase domain is phosphorylated by 3-phosphoinositide-dependent kinase-1 (PDK1) and Ser-473 in the C-terminal hydrophobic motif by a putative kinase PDK2. The identity of PDK2 has been elusive. Here we present evidence that conventional isoforms of protein kinase C (PKC), particularly PKCβII, can regulate Akt activity by directly phosphorylating Ser-473 in vitro and in IgE/antigen-stimulated mast cells. By contrast, PKCβ is not required for Ser-473 phosphorylation in mast cells stimulated with stem cell factor or interleukin-3, in serum-stimulated fibroblasts, or in antigen receptor-stimulated T or B lymphocytes. Therefore, PKCβII appears to work as a cell type- and stimulus-specific PDK2. Cell- and Stimulus-specific Serine Phosphorylation♦Journal of Biological ChemistryVol. 279Issue 46PreviewAkt is a serine/threonine kinase that is implicated in mediating a variety of biological activities including cell survival, proliferation, and glucose metabolism. Activation of Akt requires its recruitment to the plasma membrane followed by phosphorylation of Thr-308 and Ser-473. While it is known that Thr-308 is phosphorylated by 3-phosphoinositide-dependent kinase 1 (PDK1), the identity of the putative kinase, PDK2, that phosphorylates Ser-473 has remained elusive. Full-Text PDF Open Access Akt is a subfamily of the AGC serine/threonine kinases consisting of Akt1/PKBα, Akt2/PKBβ, and Akt3/PKBγ. These kinases have an N-terminal pleckstrin homology domain followed by a C-terminal kinase catalytic domain. Numerous studies implicate Akt in survival, proliferation, and glucose metabolism (reviewed in Refs. 1Vanhaesebroeck B. Alessi D.R. Biochem. J. 2000; 346: 561-576Crossref PubMed Scopus (1399) Google Scholar, 2Scheid M.P. Woodgett J.R. Nat. Rev. Mol. Cell. Biol. 2001; 2: 760-768Crossref PubMed Scopus (540) Google Scholar, 3Brazil D.P. Hemmings B.A. Trends Biochem. Sci. 2001; 26: 657-664Abstract Full Text Full Text PDF PubMed Scopus (1040) Google Scholar). Akt activation requires the recruitment of the enzyme to the plasma membrane through the interaction of the pleckstrin homology domain with plasma membrane-bound lipid products of phosphatidylinositol 3-kinase, i.e. phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 3,4-bisphosphate (4Andjelkovic M. Alessi D.R. Meier R. Fernandez A. Lamb N.J. Frech M. Cron P. Cohen P. Lucocq J.M. Hemmings B.A. J. Biol. Chem. 1997; 272: 31515-31524Abstract Full Text Full Text PDF PubMed Scopus (900) Google Scholar, 5Alessi D.R. James S.R. Downes C.P. Holmes A.B. Gaffney P.R. Reese C.B. Cohen P. Curr. Biol. 1997; 7: 261-269Abstract Full Text Full Text PDF PubMed Google Scholar, 6Stokoe D. Stephens L.R. Copeland T. Gaffney P.R. Reese C.B. Painter G.F. Holmes A.B. McCormick F. Hawkins P.T. Science. 1997; 277: 567-570Crossref PubMed Scopus (1048) Google Scholar, 7Stephens L. Anderson K. Stokoe D. Erdjument-Bromage H. Painter G.F. Holmes A.B. Gaffney P.R. Reese C.B. McCormick F. Tempst P. Coadwell J. Hawkins P.T. Science. 1998; 279: 710-714Crossref PubMed Scopus (914) Google Scholar). Membrane-bound Akt is then phosphorylated at two sites for full activation (8Alessi D.R. Andjelkovic M. Caudwell B. Cron P. Morrice N. Cohen P. Hemmings B.A. EMBO J. 1996; 15: 6541-6551Crossref PubMed Scopus (2517) Google Scholar); Thr-308 in the activation loop of the kinase domain is phosphorylated by PDK1 1The abbreviations used are: PDK, 3-phosphoinositide-dependent kinase; BMMC, bone marrow-derived mast cells; DNP, dinitrophenyl; FcϵRI, high-affinity IgE receptor; FLMC, fetal liver-derived mast cells; ILK, integrin-linked kinase; KD, kinase-dead; PKC, protein kinase C; cPKC, conventional or classical PKC isoforms; nPKC, novel PKC isoforms; PMA, phorbol 12-myristate 13-acetate; SCF, stem cell factor; wt, wild-type; IL, interleukin; HA, hemagglutinin. (5Alessi D.R. James S.R. Downes C.P. Holmes A.B. Gaffney P.R. Reese C.B. Cohen P. Curr. Biol. 1997; 7: 261-269Abstract Full Text Full Text PDF PubMed Google Scholar, 7Stephens L. Anderson K. Stokoe D. Erdjument-Bromage H. Painter G.F. Holmes A.B. Gaffney P.R. Reese C.B. McCormick F. Tempst P. Coadwell J. Hawkins P.T. Science. 1998; 279: 710-714Crossref PubMed Scopus (914) Google Scholar, 9Cohen P. Alessi D.R. Cross D.A. FEBS Lett. 1997; 410: 3-10Crossref PubMed Scopus (235) Google Scholar) and Ser-473 in the C-terminal hydrophobic motif by a putative kinase PDK2. The identity of PDK2 has been controversial (10Chan T.O. Tsichlis P.N. Science's STKE. 2001; (http://stke.sciencemag.org/cgi/content/full/sigtrans;2001/66/pe1)PubMed Google Scholar), although several PDK2 candidates including integrin-linked kinase (ILK) (11Delcommenne M. Tan C. Gray V. Rue L. Woodgett J. Dedhar S. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 11211-11216Crossref PubMed Scopus (947) Google Scholar, 12Persad S. Attwell S. Gray V. Mawji N. Deng J.T. Leung D. Yan J. Sanghera J. Walsh M.P. Dedhar S. J. Biol. Chem. 2001; 276: 27462-27469Abstract Full Text Full Text PDF PubMed Scopus (416) Google Scholar) and autophosphorylation (13Toker A. Newton A.C. J. Biol. Chem. 2000; 275: 8271-8274Abstract Full Text Full Text PDF PubMed Scopus (422) Google Scholar) have been proposed. PKC is also a subfamily of the AGC serine/threonine kinases, which are involved in proliferation, differentiation, metabolism, and cell-type specific functions (14Nishizuka Y. Science. 1992; 258: 607-614Crossref PubMed Scopus (4230) Google Scholar, 15Newton A.C. Biochem. J. 2003; 370: 361-371Crossref PubMed Scopus (663) Google Scholar). Based on structural features and cofactor requirements, PKC isoforms are classified into three categories; conventional or classical isoforms (cPKCs: α, βI, βII, and γ) depend on diacylglycerol (DAG) and Ca2+ for their activation, novel isoforms (nPKCs: δ, ϵ, η, and θ) depend on DAG, but not Ca2+, and atypical isoforms (atypical PKC isoforms: ζ and λ/ι) do not require either DAG or Ca2+. Cross-linking of high-affinity IgE receptors (FcϵRI) expressed on the surface of mast cells activates Akt (16Kitaura J. Asai K. Maeda-Yamamoto M. Kawakami Y. Kikkawa U. Kawakami T. J. Exp. Med. 2000; 192: 729-740Crossref PubMed Scopus (157) Google Scholar) and various PKC isoforms including PKCβI and PKCβII (17Kawakami Y. Kitaura J. Hartman S.E. Lowell C.A. Siraganian R.P. Kawakami T. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 7423-7428Crossref PubMed Scopus (80) Google Scholar). Importantly, Akt in mast cells is involved in FcϵRI-induced production of cytokines such as IL-2 through the activation of such transcription factors as NF-κB, NF-AT, and AP-1 (16Kitaura J. Asai K. Maeda-Yamamoto M. Kawakami Y. Kikkawa U. Kawakami T. J. Exp. Med. 2000; 192: 729-740Crossref PubMed Scopus (157) Google Scholar), and PKCβ is also required for FcϵRI-induced degranulation and cytokine production (18Nechushtan H. Leitges M. Cohen C. Kay G. Razin E. Blood. 2000; 95: 1752-1757Crossref PubMed Google Scholar). In the present study we have found that cPKC isoforms, particularly PKCβII, can regulate Akt activity by directly phosphorylating the critical residue Ser-473 in vitro and in FcϵRI-stimulated mast cells. By contrast, PKCβ is not required for Ser-473 phosphorylation in mast cells stimulated with stem cell factor (SCF) or IL-3, in serum-stimulated fibroblasts, or in antigen receptor-stimulated T or B cells. Therefore, PKCβII functions as a cell type- and stimulus-specific PDK2. Antibodies and Recombinant Proteins—Anti-FcϵRI β subunit monoclonal antibody JRK was originally donated by Dr. Juan Rivera, National Institutes of Health. Commercial sources of antibodies used were: anti-Akt (C-20), anti-PKCα (C-20), anti-PKCβI (C-16), anti-PKCβII (C-18), anti-PKCϵ (C-15), anti-PKCθ (C-19), anti-PKCζ (C-20), and anti-Vav (C-14) from Santa Cruz Biotechnology; anti-phospho-PKC (pan), a gift from Dr. Michael Comb; anti-Akt(pThr308), Akt(pS473), anti-BAD, and anti-GSK-3α(pS21) from Cell Signaling Technology; anti-HA (12CA5) from Roche Applied Science; anti-ILK and anti-c-Raf1 from Upstate Cell Signaling Solutions; and anti-FLAG from Kodak Scientific Imaging Systems. Recombinant PKCα, PKCβI, PKCβII, and PKCθ were from Invitrogen, and recombinant Akt was from Upstate Cell Signaling Solutions. Cells and Stimulation—Bone marrow cells derived from wild-type (wt), PKCβ–/–(19Leitges M. Schmedt C. Guinamard R. Davoust J. Schaal S. Stabel S. Tarakhovsky A. Science. 1996; 273: 788-791Crossref PubMed Scopus (414) Google Scholar), PKCϵ–/–(20Khasar S.G. Lin Y.H. Martin A. Dadgar J. McMahon T. Wang D. Hundle B. Aley K.O. Isenberg W. McCarter G. Green P.G. Hodge C.W. Levine J.D. Messing R.O. Neuron. 1999; 24: 253-260Abstract Full Text Full Text PDF PubMed Scopus (403) Google Scholar), and PKCθ–/–(21Sun Z. Arendt C.W. Ellmeier W. Schaeffer E.M. Sunshine M.J. Gandhi L. Annes J. Petrzilka D. Kupfer A. Schwartzberg P.L. Littman D.R. Nature. 2000; 404: 402-407Crossref PubMed Scopus (789) Google Scholar) mice were cultured in IL-3-containing medium for 4–6 weeks to generate >95% pure populations of mast cells (BMMC). Fetal liver cells were cultured in medium containing IL-3 and mouse recombinant SCF for 4–6 weeks to generate similarly pure populations of mast cells (FLMC). Mast cells cultured in SCF for more than a week are labeled as SCF-BMMC or SCF-FLMC. Mast cells were sensitized overnight with anti-dinitrophenyl (DNP) IgE monoclonal antibody and stimulated with the antigen, DNP-human serum albumin conjugates, unless otherwise mentioned. Fibroblasts were cultured from 15–18 day embryos of PKCβ+/+, PKCβ+/–, and PKCβ–/–genotypes as described previously (22Jainchill J.L. Aaronson S.A. Todaro G.J. J. Virol. 1969; 4: 549-553Crossref PubMed Google Scholar). Retroviral transduction of PKCβ–/–mast cells was done as described previously (23Kawakami Y. Kitaura J. Yao L. McHenry R.W. Newton A.C. Kang S. Kato R.M. Leitges M. Rawlings D.J. Kawakami T. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 9470-9475Crossref PubMed Scopus (65) Google Scholar). Briefly, pMX-puro plasmids harboring wt or mutant PKCβI, PKCβII, or HA-tagged Akt cDNAs were transfected into packaging cells to generate recombinant retroviruses. BMMC in culture medium containing IL-3 and SCF were infected with the viruses. Mass populations of puromycin-resistant cells were used for FcϵRI stimulation. PKCα knock-down constructs consisted of pSUPER. retro (OligoEngine) vectors containing the oligonucleotides that could be double-stranded with a loop-out. These vectors were transfected into NIH/3T3 cells to test their ability to suppress PKCα expression. The best vector was selected by immunoblotting and used to generate recombinant retrovirus, and the virus was used to infect wt and PKCβ–/–BMMC. Immunoblotting Analysis—Subcellular fractionation was performed as described previously (24Kawakami Y. Yao L. Miura T. Tsukada S. Witte O.N. Kawakami T. Mol. Cell. Biol. 1994; 14: 5108-5113Crossref PubMed Google Scholar). Otherwise, cells were lysed in 1% Nonidet P-40-containing lysis buffer. Proteins in cleared cell lysates or subcellular fractions were either immunoprecipitated before, or directly analyzed by, SDS-PAGE followed by electroblotting onto polyvinylidene difluoride membranes (Millipore). In Vitro Kinase Assays—Protein kinases either in immunoprecipitated or purified forms were incubated with synthetic peptide or recombinant protein substrate in the presence of [γ-32P]ATP. Reaction products were analyzed by SDS-PAGE and autoradiography. Alternatively, reaction mixtures were spotted onto P81 phosphocellulose filters, and the radioactivity of filters after washing in phosphoric acid was quantified. Synthetic peptides used in in vitro kinase assays were prepared in-house or purchased fromA&A Laboratories (S473tide and T308tide) or from Upstate (Crosstide), and their sequences are as follows: 1) ECVDSERRPHFPQFSYSASSTA (the underlined S indicates Ser-473, in single-letter amino acid code), used in Ser-473 phosphorylation experiments (Fig. 2a); 2) S473tide for Ser-473 phosphorylation: RRPHFPQFSYSA (Ser-473 is underlined); 3) T308tide for Thr-308 phosphorylation: KTFCGTPEYLAPEVRR (Thr-308 is underlined); Crosstide for Akt assay: GRPTSSFAEG. Measurement of Histamine and Cytokines—IgE-sensitized cells were stimulated with antigen. Histamine secreted for 45 min was measured by on-column high performance liquid IL-2 and secreted for were by Akt in to and with cPKC in Mast Akt phosphorylation can be by phorbol a DAG of BMMC derived from wt mice that phorbol 12-myristate Akt phosphorylation on Ser-473 (Fig. that PKC isoforms can Ser-473 phosphorylation was in BMMC from then Akt is with such Immunoblotting of Akt that α, βI, and is not expressed in were with and PKCβII was particularly and by FcϵRI with IgE and antigen (Fig. Akt was in by or anti-PKCβII not and were of was also with By contrast, or was not in Akt although kinases were expressed in mast cells. cPKC Akt on Ser-473 in the Akt and we Akt as a phosphorylation for cPKC we synthetic peptides to the Akt C-terminal Ser-473 can be phosphorylated by recombinant PKCα, PKCβI, and The peptide was phosphorylated by kinases with an of PKCα PKCβII PKCβI in (Fig. the peptide was not phosphorylated by of isoforms the presence in peptide of and as phosphorylation then can in Akt was not phosphorylated on Thr-308 by PKC isoforms, although the phosphorylated on or and in their activation loop the Akt Ser-473 was phosphorylated by PKCα and PKCβII in a (Fig. Ser-473 phosphorylation by PKCβI was and at than that by PKCα or PKCβII and not with its These that the particularly PKCα and PKCβII, have a PDK2 activity in vitro and can Akt on Ser-473 phosphorylation on with studies that Ser-473 phosphorylation is of Thr-308 phosphorylation (8Alessi D.R. Andjelkovic M. Caudwell B. Cron P. Morrice N. Cohen P. Hemmings B.A. EMBO J. 1996; 15: 6541-6551Crossref PubMed Scopus (2517) Google Scholar, A. J. V. Cohen P. Alessi D.R. Curr. Biol. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar, J. Hemmings B.A. Curr. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar). Akt and Ser-473 in FcϵRI-stimulated are mast cells used for studies of FcϵRI Cell surface of FcϵRI and was wt and and cell was not by PKCβ not of wt BMMC Ser-473 phosphorylation (Fig. Akt Ser-473 phosphorylation were in than in wt and Ser-473 phosphorylation were also in at antigen but more was in IgE/antigen-stimulated (Fig. (the and not BMMC and that been cultured in the presence of SCF were SCF of mast cells. with a for Ser-473 phosphorylation in Akt activation, Akt activation by as by its ability to its or was also in (Fig. and By contrast, FcϵRI-induced Ser-473 phosphorylation was not in with their wt although isoforms are expressed in These with the Ser-473 phosphorylation in (Fig. the ability of PKCβ to the isoforms to regulate Ser-473 phosphorylation in mast cells. with that of is a phosphorylation of Akt D.A. Alessi D.R. Cohen P. M. Hemmings B.A. Nature. PubMed Scopus Google Scholar, C.W. P. Science. 1997; 275: PubMed Scopus Google Scholar), phosphorylation was in (Fig. with PKCβII, but PKCβI, FcϵRI-induced Akt Ser-473 and IL-2 in Mast and PKCβII were by Y. Kikkawa U. K. T. T. Y. K. K. K. Y. Science. PubMed Scopus Google Scholar), and the of test in Akt phosphorylation and activity in are of the of PKCβI PKCβII, we cells with by the transduction which require SCF to cell to in BMMC to of mast Akt phosphorylation on Thr-308 was by PKCβ the in although with either Thr-308 phosphorylation in The Thr-308 phosphorylation to be to of PKCβI or recombinant PKCβI and PKCβII as a of PKCβI and PKCβII in the cells PKCβI, cells; PKCβI, wt PKCβII, PKCβII, in cells PKCβI, PKCβII, in wt with wt PKCβII Ser-473 phosphorylation to a full with wt PKCβI at to do (Fig. By contrast, of of PKCβI or PKCβII in to Akt that the catalytic activity of PKCβII is required for Ser-473 into immunoblotting that the BMMC used more PKCβII than PKCβI (Fig. and the in vitro Ser-473 phosphorylating activity of PKCβII PKCβI (Fig. a and that Ser-473 phosphorylation and Akt catalytic activity are of the activity of PKCβII in FcϵRI-stimulated of the which not the of Akt is that PKCβ mast cell to to SCF or is that PKCβ is involved in SCF or IL-3 H. Leitges M. Cohen C. Kay G. Razin E. Blood. 2000; 95: 1752-1757Crossref PubMed Google and not a in Thr-308 phosphorylation in was than that in Ser-473 is a that autophosphorylation of Akt to Ser-473 phosphorylation (13Toker A. Newton A.C. J. Biol. Chem. 2000; 275: 8271-8274Abstract Full Text Full Text PDF PubMed Scopus (422) Google Scholar) in mast cells. we to Ser-473 phosphorylating activity of PKCβII that the autophosphorylation of the wt and with a HA-tagged Akt a HA-tagged wt Akt and mutant Akt were also Ser-473 phosphorylation of HA-tagged wt and was in with wt cells (Fig. that of Akt protein in cells. Importantly, Ser-473 phosphorylation of HA-tagged Akt was in wt cells FcϵRI (Fig. the that Ser-473 phosphorylation is a of By contrast, Ser-473 phosphorylation of HA-tagged Akt was in (Fig. These that Ser-473 is phosphorylated by PKCβII in FcϵRI-stimulated mast cells. protein that at Ser-473 is not by PKCβ the evidence described indicates that PKCβII is a PDK2 in FcϵRI-stimulated mast we of S473tide phosphorylation by The and were in a as for T308tide phosphorylation by PDK1 for S473tide phosphorylation by PKCβII for T308tide phosphorylation by the of in vitro the of Akt with PKCβI or PKCβII were stimulated with IgE and antigen. The cells with either as as the wt BMMC (Fig. with wt PKCβII IL-2 production in that with PKCβI not (Fig. with the of Akt in FcϵRI-induced IL-2 production (16Kitaura J. Asai K. Maeda-Yamamoto M. Kawakami Y. Kikkawa U. Kawakami T. J. Exp. Med. 2000; 192: 729-740Crossref PubMed Scopus (157) Google Scholar), that Akt activation is for FcϵRI-induced IL-2 PKCα a of Akt Ser-473 in FcϵRI-stimulated Mast the in vitro PDK2 activity of PKCα (Fig. a and and to we of PKCα knock-down on Akt PKCα knock-down not Ser-473 phosphorylation in wt or of Ser-473 the it in wt BMMC These are with the of PKCβII as the PDK2 the expressed in FcϵRI-stimulated mast cells. Akt Ser-473 on and Cell into the of PKCβII as the of Ser-473 we stimulated mast cells with SCF or IL-3, two mast cell In with FcϵRI (Fig. SCF and IL-3 Ser-473 phosphorylation in to that in wt cells (Fig. T and B cells were stimulated with and monoclonal Akt was phosphorylated on Ser-473 at in wt and (Fig. and not mouse were stimulated with we similarly Ser-473 phosphorylation in wt and (Fig. These that kinases that have PDK2 or Ser-473 kinase PDK1 that was the identity of PDK2 has been of PDK2 candidates have been (10Chan T.O. Tsichlis P.N. Science's STKE. 2001; (http://stke.sciencemag.org/cgi/content/full/sigtrans;2001/66/pe1)PubMed Google 1) several kinases including ILK, 2) of PDK1 to PDK2 A. A. M. A. Gaffney P. R. Downes C.P. Alessi D.R. Curr. Biol. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar), and 3) Ser-473 autophosphorylation Thr-308 phosphorylation (13Toker A. Newton A.C. J. Biol. Chem. 2000; 275: 8271-8274Abstract Full Text Full Text PDF PubMed Scopus (422) Google Scholar). of could the PDK2 activity in several cellular that a PDK2 from ILK, or Akt is to the plasma membrane (4Andjelkovic M. Alessi D.R. Meier R. Fernandez A. Lamb N.J. Frech M. Cron P. Cohen P. Lucocq J.M. Hemmings B.A. J. Biol. Chem. 1997; 272: 31515-31524Abstract Full Text Full Text PDF PubMed Scopus (900) Google Scholar, J. Hemmings B.A. Curr. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar, M. Cron P. Hemmings B.A. Mol. Cell. Biol. 1999; PubMed Scopus Google Scholar) and is to Andjelkovic M. D.P. S. D. Hemmings B.A. J. Biol. Chem. 2001; 276: Full Text Full Text PDF PubMed Scopus Google Scholar, C.P. E.M. G.J. PubMed Scopus Google Scholar). In PDK2 activity was found in a with C.P. E.M. G.J. PubMed Scopus Google Scholar). By contrast, Ser-473 phosphorylation in FcϵRI-stimulated mast cells was and was not found in Akt from mast cell lysates (Fig. also that in Ser-473 phosphorylation in mast cells are to and depend on cell and These studies to the of PDK2 in of the that PKCβII as a PDK2 in FcϵRI-stimulated mast cells are could Akt phosphorylation on Ser-473. PKCβII was with and was and FcϵRI stimulation. with studies that Ser-473 phosphorylation at the plasma membrane L. Anderson K. Stokoe D. Erdjument-Bromage H. Painter G.F. Holmes A.B. Gaffney P.R. Reese C.B. McCormick F. Tempst P. Coadwell J. Hawkins P.T. Science. 1998; 279: 710-714Crossref PubMed Scopus (914) Google Scholar), a of PKCβII was in mast cells. PKCβII could Akt on Ser-473, and of S473tide by PKCβII were to of T308tide phosphorylation by Ser-473 phosphorylation was in FcϵRI-stimulated PKCβ–/–mast cells and phosphorylation was by with Ser-473 phosphorylation of the HA-tagged Akt was in FcϵRI-stimulated PKCβ–/–mast cells (Fig. it was in wt the of Akt autophosphorylation as the for Ser-473 and Ser-473 phosphorylation of HA-tagged Akt in FcϵRI-stimulated (Fig. could be to other PDK2 activities or a activity of the mutant although the is the of kinase activity of Akt T.O. K. A. D.R. Tsichlis P.N. Cell. Full Text PDF PubMed Scopus Google Scholar). in vitro that PKCα has a PDK2 the Ser-473 phosphorylation of HA-tagged Akt in PKCβ–/–mast cells and the with PKCα and that the of PKCα as PDK2 is at best in FcϵRI-stimulated mast cells. could be to a of membrane PKCα with that of PKCβII Y. Kitaura J. Yao L. McHenry R.W. Newton A.C. Kang S. Kato R.M. Leitges M. Rawlings D.J. Kawakami T. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 9470-9475Crossref PubMed Scopus (65) Google and not of PKCθ or not Ser-473 of the other novel or atypical PKC isoforms in BMMC are than 1 cells not kinase with PDK2 activity in mast cells be ILK, which was at a in Akt activity was not in PKCβ–/–mast cells not the that PKCβII is a PDK2 in mast cells. study that Akt Ser-473 phosphorylation is by PKCβII in a cell and that are Ser-473 kinases that are used in a cell is in with Thr-308 which is by an kinase PDK1 of that phosphatidylinositol These a to for that PKCβII or other that as a cell PDK2. Akt is implicated in the of various and of a cell of Akt than that of the phosphatidylinositol of Akt of to for of and critical of the for in of mouse and and for their of with
28
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Darren A.E. Cross, Dario R. Alessi, Philip Cohen et al. · Nature · 1995 · 5.2K citations
Mechanism of activation of protein kinase B by insulin and IGF‐1.
Dario R. Alessi, Mirjana Andjelković, B. Caudwell et al. · The EMBO Journal · 1996 · 3K citations · Full text
The PI3K–PDK1 connection: more than just a road to PKB
Bart Vanhaesebroeck, Dario R. Alessi · Biochemical Journal · 2000 · 1.6K citations · Full text